OPKOPKO Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · opko.com

1.480USD+1.37%Mkt Cap: 1.10B $P/E: —3d ago

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutic…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap1.10B $

Enterprise Value1.19B $

Revenue (TTM)587.90M $

Gross Profit205.94M $

Net Income (TTM)-225.68M $

Revenue/Share0.7540 USD

Last Price1.480 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees2.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS68375N1037

Valuation

P/E (Trailing)—

P/E (Forward)-5.31

PEG93.65

EV/EBITDA-15.18

EV/Revenue2.02

P/S1.85

P/B0.92

EPS (TTM)-0.07

EPS (Forward)-0.28

52W Range

0.980067% of range1.730

52W High1.730 USD

52W Low0.9800 USD

Profitability

Gross Margin33.93%

Oper. Margin-15.31%

EBITDA Margin-13.30%

Profit Margin-37.19%

ROE-17.80%

ROA-11.68%

Growth

Revenue Growth4.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-178.54M $

CapEx (TTM)12.28M $

FCF Margin9.32%

FCF Yield4.96%

Net Debt97.32M $

Net Debt/EBITDA-1.24

Balance Sheet

Debt/Equity0.31

Current Ratio3.35

Quick Ratio2.65

Book Value/Sh1.587 USD

Cash/Share0.4030 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)4.375 USD

Upside (mean)+195.6%

Target Range3.000 USD – 8.500 USD

$3.000+195.6% to mean$8.500

# Analysts4

Ownership

Shares Out.746.33M

Float323.73M

Insiders50.52%

Institutions27.51%

Short Interest

Short Ratio7.4d

Short % Float7.93%

Short % Out.4.41%

Shares Short32.88M

Short (prev mo.)32.59M

Technical

SMA 501.375 (+7.7%)

SMA 2001.285 (+15.2%)

Beta1.49

S&P 52W Chg18.16%

Avg Vol (30d)4.07M

Avg Vol (10d)2.44M

Technical Indicators

RSI (14)60.7

MACD0.0261

MACD Signal0.0116

MACD Hist.+0.0145

BB Upper1.562 USD

BB Middle1.361 USD

BB Lower1.159 USD

BB Width29.58%

ATR (14)0.0764 USD

Vol Ratio (20d)0.55x